Patents Represented by Attorney Kenneth A. Weber

Find this attorney in the Justia Lawyer Directory

  • Purified mammalian CTLA-8 antigens and related reagents
    Patent number: 6562333
    Abstract: CTLA-8 antigen from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said antigen. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: May 13, 2003
    Assignee: Schering Corporation
    Inventors: Pierre Golstein, Eric Rouvier, François Fossiez, Serge J. E. Lebecque
  • Purified mammalian CTLA-8 antigens and related reagents
    Patent number: 6274711
    Abstract: CTLA-8 antigen from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said antigen. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: August 14, 2001
    Assignees: INSERM, Institut National de la Sante et de la Recherche Medicale, Schering Corporation
    Inventors: Pierre Golstein, Eric Rouvier, Francois Fossiez, Serge J. E. Lebecque, Odile Djossou, Jacques Banchereau
  • Method of inducing calcium flux in cells using mammalian thymokine protein
    Patent number: 6245329
    Abstract: Nucleic acids encoding a thymokine from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 12, 2001
    Assignee: Schering Corporation
    Inventors: Gregory S. Kelner, Jacqueline L. Kennedy, Albert Zlotnik
  • Antibodies which specifically bind to the thymokine lymphotactin
    Patent number: 5985580
    Abstract: Nucleic acids encoding a thymokine designated lymphotactin from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 16, 1999
    Assignee: Schering Corporation
    Inventors: Gregory S. Kelner, Jacqueline L. Kennedy, Albert Zlotnik
  • Mammalian thymokine having leukocyte chemotactic activity, and fragments thereof
    Patent number: 5877285
    Abstract: Nucleic acids encoding a thymokine from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 2, 1999
    Assignee: Schering Corporation
    Inventors: Gregory S. Kelner, Jacqueline L. Kennedy, Albert Zlotnik
  • Mammalian thymokine genes
    Patent number: 5786210
    Abstract: Nucleic acids encoding a thymokine from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: October 25, 1994
    Date of Patent: July 28, 1998
    Assignee: Schering Corporation
    Inventors: Gregory S. Kelner, Jacqueline L. Kennedy, Albert Zlotnik
  • Method of reducing immunoglobulin E responses
    Patent number: 5676940
    Abstract: A method of reducing immunoglobulin E responses associated with certain immune disorders is provided. The method comprises administering an effective amount of an antagonist to human interleukin-4. Preferably, the antagonist is a blocking monoclonal antibody specific for human interleukin-4, or a fragment or binding composition derived therefrom.
    Type: Grant
    Filed: March 17, 1994
    Date of Patent: October 14, 1997
    Assignee: Schering Corporation
    Inventors: Robert L. Coffman, Jan Egbert de Vries
  • Vaccines for human respiratory virus
    Patent number: 5149650
    Abstract: This invention discloses compositions of DNA and proteins that are useful for preparing vaccines against human respiratory syncytial virus [HRSV]. The DNA compositions include structural genes coding for native structural viral proteins and immunogenic fragments of these proteins. Host cells transformed with the above DNA compositions are also disclosed. Vaccines made from the native structural viral proteins or immunogenic fragments are also disclosed as well as methods for protecting humans by inoculation with these vaccines.
    Type: Grant
    Filed: July 13, 1988
    Date of Patent: September 22, 1992
    Assignee: University of North Carolina at Chapel Hill
    Inventors: Gail W. Wertz, Peter L. Collins
  • Composition of matter and process
    Patent number: 4782135
    Abstract: Novel antibiotics didemnins A, B and C (didemnins), and nordidemnins A, B and C (nordidemnins) which can be obtained from a marine organism. These antibiotics are active against a variety of DNA and RNA viruses; thus, they can be used in various environments to control or eradicate these viruses. Further, these antibiotics have demonstrated therapeutic value against two murine cancer types.
    Type: Grant
    Filed: January 13, 1983
    Date of Patent: November 1, 1988
    Assignee: Board of Trustees, University of Illinois
    Inventor: Kenneth L. Rinehart, Jr.
  • Antiviral eudistomins from a marine tunicate
    Patent number: 4631149
    Abstract: The subject invention concerns novel and useful antiviral compounds referred to as eudistomins. These compounds are obtainable from well-known and available marine organisms. Their utility is as antiviral agents as well as antibacterial and antitumor agents in some cases.
    Type: Grant
    Filed: February 9, 1984
    Date of Patent: December 23, 1986
    Assignee: University of Illinois
    Inventors: Kenneth L. Rinehart, Jr., Gary C. Harbour, Jun'ichi Kobayashi
  • Acylation of tirandamycic, streptolic and sorbic acids to cephalosporin and penicillin nuclei
    Patent number: 4623644
    Abstract: This invention relates to the hybridization of streptolydigin, tirandamycin and sorbic acid to penicillin and cephalosporin nuclei.
    Type: Grant
    Filed: August 7, 1985
    Date of Patent: November 18, 1986
    Assignee: The Upjohn Company
    Inventors: Fritz Reusser, Kenneth L. Rinehart, Jr.
  • N-imidoylthio(methyl)carbamates
    Patent number: 4592871
    Abstract: This invention pertains to some new organic compounds, to a process for preparing them, and to formulations of them suitable for pesticidal use. The invention is more particularly directed to imidic acid derivatives of N-thio(methyl)carbamates.
    Type: Grant
    Filed: May 31, 1984
    Date of Patent: June 3, 1986
    Assignee: The Upjohn Company
    Inventors: Fred E. Dutton, Stephen J. Nelson
  • Macrocyclic lactones
    Patent number: 4560774
    Abstract: New and exceptionally potent antineoplastic agents designated bryostatin 1, bryostatin 2 and bryostatin 3 have been isolated from the marine animal Bugula neritina L. (Bryozoan phylum). An x-ray crystallographic analysis led to the assignment of novel structures shown in Charts I, II and III.
    Type: Grant
    Filed: July 12, 1983
    Date of Patent: December 24, 1985
    Assignee: Arizona State University
    Inventors: George R. Pettit, Cherry L. Herald
  • Artichoke plant named ‘BCL 9-11’
    Patent number: PP15807
    Abstract: A new and distinct cultivar of Artichoke plant named ‘BCL 9-11’ characterized by numerous very large semi-glossy heads and thick, fleshy bracts and hears. The heads is rounder than the parent lines with reduced pubescence. The bracts are more compact that its parents.
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: June 28, 2005
    Inventor: Medhat Chahbandar